Filing Details
- Accession Number:
- 0000899243-17-025039
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-31 20:15:01
- Reporting Period:
- 2017-10-30
- Accepted Time:
- 2017-10-31 20:15:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1629137 | Global Blood Therapeutics Inc. | GBT | Pharmaceutical Preparations (2834) | 274825712 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1650131 | Peter Radovich | C/O Global Blood Therapeutics, Inc. 400 East Jamie Court, Suite 101 South San Francisco CA 94080 | Senior Vp, Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-10-30 | 12,500 | $35.00 | 0 | No | 4 | S | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,684 | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.